US20060091058A1 - Blood Treatment Dialyzer/Filter Design to Remove Entrained Gas and Add Medicaments - Google Patents

Blood Treatment Dialyzer/Filter Design to Remove Entrained Gas and Add Medicaments Download PDF

Info

Publication number
US20060091058A1
US20060091058A1 US11/163,708 US16370805A US2006091058A1 US 20060091058 A1 US20060091058 A1 US 20060091058A1 US 16370805 A US16370805 A US 16370805A US 2006091058 A1 US2006091058 A1 US 2006091058A1
Authority
US
United States
Prior art keywords
blood
syringe
header
medicament
port
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/163,708
Inventor
James BRUGGER
Martin Stillig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NxStage Medical Inc
Original Assignee
NxStage Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NxStage Medical Inc filed Critical NxStage Medical Inc
Priority to US11/163,708 priority Critical patent/US20060091058A1/en
Assigned to NXSTAGE MEDICAL INC. reassignment NXSTAGE MEDICAL INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: STILLIG, MARTIN, BRUGGER, JAMES M.
Publication of US20060091058A1 publication Critical patent/US20060091058A1/en
Assigned to GE BUSINESS FINANCIAL SERVICES INC. reassignment GE BUSINESS FINANCIAL SERVICES INC. SECURITY AGREEMENT Assignors: EIR MEDICAL, INC., MEDISYSTEMS CORPORATION, MEDISYSTEMS SERVICES CORPORATION, NXSTAGE MEDICAL, INC.
Priority to US12/432,507 priority patent/US7901579B2/en
Assigned to EIR MEDICAL, INC., MEDISYSTEMS CORPORATION, NXSTAGE MEDICAL, INC., MEDISYSTEMS SERVICES CORPORATION reassignment EIR MEDICAL, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: GE BUSINESS FINANCIAL SERVICES INC.
Priority to US13/025,306 priority patent/US20110126714A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3627Degassing devices; Buffer reservoirs; Drip chambers; Blood filters
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D19/00Degasification of liquids
    • B01D19/0021Degasification of liquids by bringing the liquid in a thin layer
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D19/00Degasification of liquids
    • B01D19/0042Degasification of liquids modifying the liquid flow
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14Ultrafiltration; Microfiltration
    • B01D61/20Accessories; Auxiliary operations
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/24Dialysis ; Membrane extraction
    • B01D61/30Accessories; Auxiliary operation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D63/00Apparatus in general for separation processes using semi-permeable membranes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D63/00Apparatus in general for separation processes using semi-permeable membranes
    • B01D63/02Hollow fibre modules
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D65/00Accessories or auxiliary operations, in general, for separation processes or apparatus using semi-permeable membranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/15Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with a cassette forming partially or totally the flow circuit for the treating fluid, e.g. the dialysate fluid circuit or the treating gas circuit
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2313/00Details relating to membrane modules or apparatus
    • B01D2313/06External membrane module supporting or fixing means
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2313/00Details relating to membrane modules or apparatus
    • B01D2313/18Specific valves

Definitions

  • Treatment systems normally have air detectors to prevent air from being injected into a patient, either because a venous line carrying blood back to the patient contains air or because an infusate line, such as the replacement fluid line of a hemofiltration system, contains air. It is desirable for the air detectors to be made sufficiently sensitive to prevent the rare instances of long trains of air bubbles being injected into a patient. But sensitivity high enough to prevent long thin trains of bubbles may be high enough to alarm very small amounts of air which pose no risk. In other words, sensitive air detectors alarm on a lot of fall positives if they protect against all possible risks.
  • Air-settling chambers necessarily involve stagnant flow, which creates a risk of forming clots (e.g., for blood) or sedimentation or other concentration of entrained material (e.g. medication).
  • Another prior art problem is stagnant flow in the headers of microtubular filter used for most dialyzers and hemofilters. This is a particular problem in the venous header where flow from many microtubules coalesces into a single slow moving flow.
  • FIG. 1 is a cross-section view of a filter usable in a variety of different types of blood treatment systems oriented to trap air in one or two header portions of the filter.
  • FIGS. 2A through 2C illustrate holders for use with the filter device embodiment described herein, including a particular example of application to a blood treatment device such as that of FIG. 1 .
  • FIG. 2D illustrates an example of a holder feature to restrict orientations of a filter ensure that the filter is oriented with respect to the force of gravity.
  • FIG. 3 illustrates a filter similar to that of FIG. 1 but with a header port for removing air and/or disrupting or cleaning clots.
  • FIG. 4A illustrates an assembly for use with the port of FIG. 3 for removing air and/or disrupting or cleaning clots.
  • FIG. 4B illustrates a drip-chamber (or bubble trap) embodiment similar to the embodiment of FIG. 4A .
  • FIG. 5 illustrates a header cap with a hydrophobic membrane for automatically venting air.
  • FIGS. 6A through 9B illustrate a method for manufacturing a filter having a two-piece header caps that allow the use of a cylinder for a majority of the filter.
  • FIGS. 10A, 10B , and 11 illustrate the filter whose manufacture is described with respect to FIGS. 6A through 9B .
  • FIG. 12 shows an alternative configuration for connecting a dialysate manifold with a tubular body of the a filter according to an embodiment of the invention.
  • FIG. 13 illustrates a single element header component that uses a simple tube for the dialysate portion.
  • FIG. 1 is a cross-section view of a filter usable in a variety of different types of blood treatment systems oriented to trap air in one or two header portions of the filter.
  • a filter 100 which may be a dialyzer, hemofilter, hemodiafilter, or any other compatible blood treatment has a bundle of tubular media 132 connecting an arterial 160 and venous 155 head space which is isolated from a filtrate space 130 .
  • Blood flows through ports 122 and 124 in header caps 110 and 136 as indicated by arrows 118 and 112 into and out of the arterial 160 and venous 155 head spaces, respectively.
  • a cylindrical filter body 128 encloses the filtrate space 130 and contains filtrate (e.g., dialyzer) ports 126 and 120 .
  • Arterial and venous headers 142 and 134 isolate the filtrate space 130 from the respective arterial 160 and venous 155 head spaces.
  • the orientation of the filter 100 with respect to the pull of gravity is shown with the understanding that gravity is assumed to pull down with respect to the profile orientation of the drawing page. If any air is entrained in the blood, it may settle in pockets 151 and 153 in the arterial 160 and venous 155 head spaces as indicated by air/liquid interfaces 152 and 150 . The flow of blood through the arterial 160 and venous 155 head spaces is extremely slow due to the very small cross-sectional areas of the filter fibers in the bundle 132 . As a result, the arterial 160 and venous 155 head spaces are an idea place for air to settle out. With the indicated orientation, with blood outlet 124 pointing down and away from the pocket 151 . Since the blood moves at a very slow rate in the arterial 160 and venous 155 head spaces, there is little risk of reentrainment and air settles out very effectively.
  • Air trapped in pocket 153 may travel through filter fibers in bundle 132 up to venous head space 155 and accumulate in pocket 151 . Since the pocket 153 is located near the top of the arterial head space 160 , air will tend to travel up a few of the fibers closest to the top and collect in the pocket 151 without mixing in with blood. This keeps the vast majority of fibers filled with blood.
  • FIGS. 2A through 2C illustrate holder variations for the filter embodiments of the present patent disclosure.
  • the variations are intended to illustrate examples and not intended to be comprehensive or limiting.
  • a holder 175 of a blood treatment machine orients a filter such as that of FIG. 1 and those of the further filter embodiments described below.
  • the holder 175 may be attached at a base thereof (not shown separately) to a blood treatment machine 172 which may contain actuators, sensors, and control elements as well as a fluid circuit, here illustrated as a cartridge 180 enclosed between two parts 171 and 172 of the blood treatment machine 172 .
  • a filter 100 that is preconnected to the fluid circuit can easily be mounted in such an apparatus.
  • the holder 175 may be articulating to allow for some movement or change of orientation of the filter 100 and is preferably a spring-tensioned clamp that allows for one-handed insertion of a filter 100 .
  • the holder 175 may be attached to the 180 cartridge such that its orientation is obtained when the cartridge 180 is positioned with respect to the blood treatment machine 170 .
  • a holder 194 is integrated into a disposable unit 190 (such as the fluid circuit cartridge of FIG. 2A ).
  • the holder 194 may be made of wire which is connected to a plastic panel support 191 of the disposable unit. Examples of such disposable units are disclosed in U.S. Pat. No. 6,955,655 for “Hemofiltration system” and U.S. Pat.
  • the holder 194 supports a filter 192 such that when the disposable unit 190 is mounted, in a treatment device such as 170 , the filter 192 is held at an angle as shown.
  • FIG. 2C Another alternative arrangement shown in FIG. 2C is to provide a separate support 178 that is attached, or attachable, to a support 176 .
  • FIG. 2D illustrates an example of a holder feature to restrict orientations of a filter ensure that the filter is oriented with respect to the force of gravity.
  • the view is a sectional view.
  • the filter 166 has tabs 162 and 164 that prevent the filter 166 from being received fully within a flexible trough 168 which functions as a holder. This may be confirmed by inspection.
  • the flexible trough 168 allows the filter 166 body to fit into it fully in only one orientation, the holder providing an urging force that keeps the filter 166 in place when inserted.
  • FIG. 2D is only one of many devices that may be used to restrict the orientation of the filter when attached to a holder and is not intended to be limiting of the scope of any of the inventions described in the present disclosure.
  • FIG. 3 illustrates a filter similar to that of FIG. 1 but with a header cap 210 having an integrated header port 200 for removing air and/or disrupting or cleaning clots.
  • Tubing 265 may be connected to the port and provided with a clamp 260 .
  • the clamp 260 may be released, at intervals, by an operator, to vent air from the air pocket 251 and re-engaged to prevent blood loss.
  • the clamp 260 may be a normally-closed type clamp with a strong spring so that it reclamps tubing 265 when released.
  • the tubing 265 may be capped with a microporous filter end cap 253 to prevent any contamination re-entering the blood in the venous head space 155 .
  • the entire assembly that includes the filter 100 , tubing 265 , and microporous filter end cap 253 may be fused, sealed, and sterilized as a unit.
  • the same may be fused, sealed and sterilized as a unit with an entire treatment circuit, combining it with the circuit described in U.S. patent application Ser. No. 10/650,935 published as US 2004-0069709, which is hereby incorporated by reference as if full set forth in its entirety herein. With this combination, the entire circuit may be isolated from contamination.
  • FIG. 4A illustrates an assembly 350 for use with the port of FIG. 3 for removing air and/or disrupting or cleaning clots.
  • the port 200 has a tube 310 connecting the venous head space 155 with a multi-way valve (e.g., a stopcock as shown) 312 .
  • the multi-way valve 312 is further connected to a syringe 320 and tubing 375 connecting a supply of blood normal saline 375 , heparin, drug, or other medicament (such as from a tube 360 and bag 365 ) such as anticoagulants, drugs, etc.
  • the multi-way valve allows the syringe to be connected, in a first position, to draw saline from the source of saline 375 and, in a second position, to draw air from the venous head space 155 .
  • saline may be pushed into the head space 155 to clear clots or for prophylaxis by injecting medicament, for example, an anticoagulant such as heparin.
  • the multi-way valve 312 is set in the second position and air is drawn from the head space 155 . Then it is set in the first position and saline is drawn into the syringe 320 .
  • the multi-way valve 312 is set in the second position again and saline (or saline and heparin) is injected into the venous head space 155 .
  • the apparatus including the multi-way valve 312 , syringe 320 , tubing 310 , 375 , 360 and clamp 260 may be pre-attached to the filter 100 and presterilized as a unit.
  • a drip chamber 393 (which could also be a bubble trap or other similar device in which air may accumulate and possibly be vented), has an inlet 391 and an outlet 394 .
  • a connection 392 to the top of the drip chamber 393 may be connected to the line 310 shown in FIG. 4A and used in the manner described for removing air and/or injecting medicaments.
  • FIG. 5 illustrates a header cap 210 with cover 280 sealed to and covering the header port 200 .
  • the cover includes a hydrophobic membrane 285 that allows air in the head space 155 to vent automatically while preventing any contamination from entering.
  • a method for manufacturing a filter design begins with the insertion of a filter fiber bundle 420 into a cylindrical tube 405 which forms part of a housing (discussed with reference to FIG. 11 ).
  • the tube 405 is a straight tube with no other structural features, in the present example.
  • the tube 405 may be a thin walled structure allowing material to be saved.
  • it may be made of a material that is not necessarily injection moldable, as filter housings generally are.
  • a preferred material is glycol-modified polyethylene terephthalate, a copolyester (PETG) which may be a clear amorphous thermoplastic with high stiffness, hardness, and toughness as well as good impact strength.
  • PETG copolyester
  • Other advantages of using a tube for the main part of the housing will become clear from the further description below. Note that in the drawing only one end of the tube is shown in the present and following figures, but a complementary operation may be performed at an opposite end of the tube 405 such that a mirror-image structure is obtained.
  • the filter fiber membrane bundle 420 may be inserted such that the fibers 415 extend beyond the end 407 of the tube 405 as indicated at 445 .
  • the resulting combination 430 of tube 405 and filter fibers 420 may be inserted in a dialysis cap 435 .
  • dialysis cap is for convenience is not intended to limit the scope of the invention to the manufacture of a dialyzer.
  • the outer surface of the tube 405 lies adjacent an inner annular surface 440 of the dialysis cap and a 450 bond is formed by thermal welding or sealing using adhesive, solvent, or filling type bonding agent such as urethane to form a completed structure 480 .
  • a symmetrical structure is formed at the opposite end so that both ends of the tube 405 have a dialysate cap 435 .
  • potting caps are placed over the ends of the structure 480 and the ends of the fiber bundle are potted as according methods that are known in the art of manufacturing filters.
  • a preferred method of potting is described in U.S. Pat. No. 6,872,346 for a “Method and apparatus for manufacturing filters,” which is hereby incorporated by reference as if fully set forth in its entirety herein.
  • the result of potting is the creation of a sealed end of potting material indicated at 440 which, after hardening, is cut along a planar surface indicated at 460 .
  • the cut 460 is done in such a way that the end of the filter fibers 420 are open at the surface 465 forming.
  • a portion of the dialysate cap 435 may be trimmed off in the process of cutting 460 , as illustrated, although it will be apparent to those skilled in the art that this is not essential and instead, the fibers 420 could extend beyond the end of the dialysate cap 435 before potting such that the fibers 420 can be opened by cutting without cutting the dialysis cap 435 .
  • the completed end portion is shown in FIG. 8B , and as discussed, a symmetrical end portion may be completed at the opposite end (not shown here).
  • Respective blood caps 505 and 605 are fitted to the ends 600 A and 600 B of the structure 480 .
  • Each blood cap has a respective blood port 510 , 610 and one of the blood caps has a secondary port 610 which will be recognized from the discussion of embodiments such as shown and discussed with respect to FIGS. 3 through 5 .
  • the blood caps 505 and 605 have respective header spaces 645 that are preferably hydraulically shaped to ensure that no, or a minimal number of, dead (stagnant flow of blood) spaces arise when in use.
  • a rim 515 fits into an annular recess 470 (or rim 615 into annular recess 471 ).
  • a bead 605 , 606 , 607 , 608 of adhesive or sealing material may be applied or injected in the annular recesses 470 and 471 to form a bond between the structure 480 and the respective blood caps 505 and 605 .
  • the bonding may be done by thermal, friction, solvent welding, compression bonding, or other technique.
  • Dialysate ports 30 and 531 in the dialysate caps 435 and 425 allow dialysate to flow into and out of the space occupied by bundle 420 and in contact with the external surfaces of the filter bundle 420 .
  • a hemofilter or other kinds of filters such as sterile filters, reverse osmosis filters, ultrafilters, etc.; only one “dialysate” port would be required.
  • Blood ports 510 and 610 in blood caps 505 and 605 respectively, supply blood into, and be recovered from, the header spaces 545 and 645 , respectively. Air can be removed from air removal/access port 610 . As explained above, removal/access port 610 can also be used for injection of anticoagulants, drugs, or other medicaments.
  • a small gap 685 , 686 is provided between the end 407 ( FIGS. 6A, 7A , 8 A) of the tube 405 ( FIGS. 6A, 6B ) and the surface of the potting 440 to allow dialysate to flow into the space occupied by the filter bundle 420 .
  • the dialysate (or filtrate, depending on the application) is distributed by an annular dialysate manifold space 626 , 626 .
  • FIG. 11 shows a complete filter unit.
  • One of the benefits of the design is that it makes it possible to confine the capital expense associated with injection molding to the dialysate and blood header reducing first costs in new filter designs.
  • the design allows the tubular portion to be lengthened and shorted without requiring major design and manufacturing changes.
  • injection molding is not contemplated to be a requirement for the practice of the invention or all its embodiments, it is a preferred means for achieving the high precision and economies of scale for articles of manufacture such as dialyzers, filters, and hemofilters, as well as other applications of the disclosed embodiments.
  • a tube for the filtrate/dialysate portion of the filter can be obtained by using a single-element header cap rather than separate “dialysate” and “blood” caps.
  • a one-piece cap 725 has an annular dialysate manifold 740 that is sealed by O-rings 747 against the surface of a tube 760 .
  • a blood header space 732 is in communication with a blood port 730 and the dialysate manifold 740 is in communication with a dialysate port 735 .
  • Slits 750 (configured such as illustrated in FIG. 11 ) allow fluid communication between the dialysate manifold 740 and the external surfaces of the fiber bundle 733 .
  • a potting plug 745 in addition to performing its normal function, serves to reinforce the cylindrical structure of the tube 760 against the pressure of the O-ring 747 seals.
  • a tube is permitted to be used with a single-element cap 725 structure providing many of the benefits of the inventions discussed above.
  • a tension band 757 may be used to ensure a good seal and provide a final shape to the one-piece cap 725 if made of a somewhat compliant resin to allow it to be removed from an injection mold despite the recess defined by the dialysate manifold 740 .
  • the one-piece cap 725 may have a discontinuous dialysate manifold that allows it to be created without requiring the cap to yield, the cap could be machined rather than molded, or the cap could be made of two molded pieces that are assembled into a single cap. Many variations are possible.

Abstract

A configuration of a blood microtubular filter/dializer used in many kinds of renal replacement therapy systems can provide highly a effective mechanism for removing air from the blood circuit of such systems. In embodiments, for example, the invention takes advantage of the slow flow rate that usually occurs where blood exits the microtubules into a header area of the filter to provide a settling area and an auxiliary port with a multi-way valve allowing gas to be drawn out from the header and for medicaments to be injected into said header.

Description

    BACKGROUND
  • One of the problems with fluid circuits in blood treatment systems is entrained air (bubbles) in treatment fluids, infusate, or blood. Treatment systems normally have air detectors to prevent air from being injected into a patient, either because a venous line carrying blood back to the patient contains air or because an infusate line, such as the replacement fluid line of a hemofiltration system, contains air. It is desirable for the air detectors to be made sufficiently sensitive to prevent the rare instances of long trains of air bubbles being injected into a patient. But sensitivity high enough to prevent long thin trains of bubbles may be high enough to alarm very small amounts of air which pose no risk. In other words, sensitive air detectors alarm on a lot of fall positives if they protect against all possible risks.
  • A prior art approach has been to remove as much air from a protected fluid circuit as possible. Putting air traps in fluid circuits, particularly blood lines, has drawbacks. Air-settling chambers necessarily involve stagnant flow, which creates a risk of forming clots (e.g., for blood) or sedimentation or other concentration of entrained material (e.g. medication).
  • Another prior art problem is stagnant flow in the headers of microtubular filter used for most dialyzers and hemofilters. This is a particular problem in the venous header where flow from many microtubules coalesces into a single slow moving flow.
  • The inventive embodiments provide various other features and advantages in addition to or in lieu of those discussed above and below. Many of these features and advantages are apparent from the description below with reference to the following drawing.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a cross-section view of a filter usable in a variety of different types of blood treatment systems oriented to trap air in one or two header portions of the filter.
  • FIGS. 2A through 2C illustrate holders for use with the filter device embodiment described herein, including a particular example of application to a blood treatment device such as that of FIG. 1.
  • FIG. 2D illustrates an example of a holder feature to restrict orientations of a filter ensure that the filter is oriented with respect to the force of gravity.
  • FIG. 3 illustrates a filter similar to that of FIG. 1 but with a header port for removing air and/or disrupting or cleaning clots.
  • FIG. 4A illustrates an assembly for use with the port of FIG. 3 for removing air and/or disrupting or cleaning clots.
  • FIG. 4B illustrates a drip-chamber (or bubble trap) embodiment similar to the embodiment of FIG. 4A.
  • FIG. 5 illustrates a header cap with a hydrophobic membrane for automatically venting air.
  • FIGS. 6A through 9B illustrate a method for manufacturing a filter having a two-piece header caps that allow the use of a cylinder for a majority of the filter.
  • FIGS. 10A, 10B, and 11 illustrate the filter whose manufacture is described with respect to FIGS. 6A through 9B.
  • FIG. 12 shows an alternative configuration for connecting a dialysate manifold with a tubular body of the a filter according to an embodiment of the invention.
  • FIG. 13 illustrates a single element header component that uses a simple tube for the dialysate portion.
  • DETAILED DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a cross-section view of a filter usable in a variety of different types of blood treatment systems oriented to trap air in one or two header portions of the filter. A filter 100, which may be a dialyzer, hemofilter, hemodiafilter, or any other compatible blood treatment has a bundle of tubular media 132 connecting an arterial 160 and venous 155 head space which is isolated from a filtrate space 130. Blood flows through ports 122 and 124 in header caps 110 and 136 as indicated by arrows 118 and 112 into and out of the arterial 160 and venous 155 head spaces, respectively. A cylindrical filter body 128 encloses the filtrate space 130 and contains filtrate (e.g., dialyzer) ports 126 and 120. Arterial and venous headers 142 and 134 isolate the filtrate space 130 from the respective arterial 160 and venous 155 head spaces.
  • The orientation of the filter 100 with respect to the pull of gravity is shown with the understanding that gravity is assumed to pull down with respect to the profile orientation of the drawing page. If any air is entrained in the blood, it may settle in pockets 151 and 153 in the arterial 160 and venous 155 head spaces as indicated by air/ liquid interfaces 152 and 150. The flow of blood through the arterial 160 and venous 155 head spaces is extremely slow due to the very small cross-sectional areas of the filter fibers in the bundle 132. As a result, the arterial 160 and venous 155 head spaces are an idea place for air to settle out. With the indicated orientation, with blood outlet 124 pointing down and away from the pocket 151. Since the blood moves at a very slow rate in the arterial 160 and venous 155 head spaces, there is little risk of reentrainment and air settles out very effectively.
  • Air trapped in pocket 153 may travel through filter fibers in bundle 132 up to venous head space 155 and accumulate in pocket 151. Since the pocket 153 is located near the top of the arterial head space 160, air will tend to travel up a few of the fibers closest to the top and collect in the pocket 151 without mixing in with blood. This keeps the vast majority of fibers filled with blood.
  • FIGS. 2A through 2C illustrate holder variations for the filter embodiments of the present patent disclosure. The variations are intended to illustrate examples and not intended to be comprehensive or limiting. In FIG. 2A, a holder 175 of a blood treatment machine orients a filter such as that of FIG. 1 and those of the further filter embodiments described below. The holder 175 may be attached at a base thereof (not shown separately) to a blood treatment machine 172 which may contain actuators, sensors, and control elements as well as a fluid circuit, here illustrated as a cartridge 180 enclosed between two parts 171 and 172 of the blood treatment machine 172. A filter 100 that is preconnected to the fluid circuit can easily be mounted in such an apparatus. The holder 175 may be articulating to allow for some movement or change of orientation of the filter 100 and is preferably a spring-tensioned clamp that allows for one-handed insertion of a filter 100. In an alternative embodiment, the holder 175 may be attached to the 180 cartridge such that its orientation is obtained when the cartridge 180 is positioned with respect to the blood treatment machine 170. In FIG. 2B, a holder 194 is integrated into a disposable unit 190 (such as the fluid circuit cartridge of FIG. 2A). For example, the holder 194 may be made of wire which is connected to a plastic panel support 191 of the disposable unit. Examples of such disposable units are disclosed in U.S. Pat. No. 6,955,655 for “Hemofiltration system” and U.S. Pat. No. 6,579,253 for “Fluid processing systems and methods using extracorporeal fluid flow panels oriented within a cartridge,” each of which is hereby incorporated by reference as if full set forth in its entirety herein and U.S. patent application Ser. No. 10/650,935 published as US 2004-0069709, which is incorporated by reference above. The holder 194 supports a filter 192 such that when the disposable unit 190 is mounted, in a treatment device such as 170, the filter 192 is held at an angle as shown. Another alternative arrangement shown in FIG. 2C is to provide a separate support 178 that is attached, or attachable, to a support 176.
  • FIG. 2D illustrates an example of a holder feature to restrict orientations of a filter ensure that the filter is oriented with respect to the force of gravity. The view is a sectional view. In the example, the filter 166 has tabs 162 and 164 that prevent the filter 166 from being received fully within a flexible trough 168 which functions as a holder. This may be confirmed by inspection. The flexible trough 168 allows the filter 166 body to fit into it fully in only one orientation, the holder providing an urging force that keeps the filter 166 in place when inserted. Note that the example illustrated in FIG. 2D is only one of many devices that may be used to restrict the orientation of the filter when attached to a holder and is not intended to be limiting of the scope of any of the inventions described in the present disclosure.
  • FIG. 3 illustrates a filter similar to that of FIG. 1 but with a header cap 210 having an integrated header port 200 for removing air and/or disrupting or cleaning clots. Tubing 265 may be connected to the port and provided with a clamp 260. The clamp 260 may be released, at intervals, by an operator, to vent air from the air pocket 251 and re-engaged to prevent blood loss. The clamp 260 may be a normally-closed type clamp with a strong spring so that it reclamps tubing 265 when released. The tubing 265 may be capped with a microporous filter end cap 253 to prevent any contamination re-entering the blood in the venous head space 155. The entire assembly that includes the filter 100, tubing 265, and microporous filter end cap 253 may be fused, sealed, and sterilized as a unit. In addition the same may be fused, sealed and sterilized as a unit with an entire treatment circuit, combining it with the circuit described in U.S. patent application Ser. No. 10/650,935 published as US 2004-0069709, which is hereby incorporated by reference as if full set forth in its entirety herein. With this combination, the entire circuit may be isolated from contamination.
  • FIG. 4A illustrates an assembly 350 for use with the port of FIG. 3 for removing air and/or disrupting or cleaning clots. The port 200 has a tube 310 connecting the venous head space 155 with a multi-way valve (e.g., a stopcock as shown) 312. The multi-way valve 312 is further connected to a syringe 320 and tubing 375 connecting a supply of blood normal saline 375, heparin, drug, or other medicament (such as from a tube 360 and bag 365) such as anticoagulants, drugs, etc. The multi-way valve allows the syringe to be connected, in a first position, to draw saline from the source of saline 375 and, in a second position, to draw air from the venous head space 155. In the second position, saline may be pushed into the head space 155 to clear clots or for prophylaxis by injecting medicament, for example, an anticoagulant such as heparin. In an illustrative usage method, the multi-way valve 312 is set in the second position and air is drawn from the head space 155. Then it is set in the first position and saline is drawn into the syringe 320. Then the multi-way valve 312 is set in the second position again and saline (or saline and heparin) is injected into the venous head space 155. The apparatus including the multi-way valve 312, syringe 320, tubing 310, 375, 360 and clamp 260 may be pre-attached to the filter 100 and presterilized as a unit.
  • Note that besides using the multi-way valve and bag 365 to draw air from the header of a filter and inject medicaments into the filter header, the same devices may be used in connection with an air trap or drip chamber. Referring to FIG. 4B, a drip chamber 393 (which could also be a bubble trap or other similar device in which air may accumulate and possibly be vented), has an inlet 391 and an outlet 394. A connection 392 to the top of the drip chamber 393 may be connected to the line 310 shown in FIG. 4A and used in the manner described for removing air and/or injecting medicaments.
  • FIG. 5 illustrates a header cap 210 with cover 280 sealed to and covering the header port 200. The cover includes a hydrophobic membrane 285 that allows air in the head space 155 to vent automatically while preventing any contamination from entering.
  • Referring to FIGS. 6A and 6B, a method for manufacturing a filter design that incorporates features of the foregoing examples begins with the insertion of a filter fiber bundle 420 into a cylindrical tube 405 which forms part of a housing (discussed with reference to FIG. 11). The tube 405 is a straight tube with no other structural features, in the present example. As such, the tube 405 may be a thin walled structure allowing material to be saved. In addition, it may be made of a material that is not necessarily injection moldable, as filter housings generally are. A preferred material is glycol-modified polyethylene terephthalate, a copolyester (PETG) which may be a clear amorphous thermoplastic with high stiffness, hardness, and toughness as well as good impact strength. Other advantages of using a tube for the main part of the housing will become clear from the further description below. Note that in the drawing only one end of the tube is shown in the present and following figures, but a complementary operation may be performed at an opposite end of the tube 405 such that a mirror-image structure is obtained.
  • The filter fiber membrane bundle 420 may be inserted such that the fibers 415 extend beyond the end 407 of the tube 405 as indicated at 445. Referring now to FIGS. 7A and 7B, the resulting combination 430 of tube 405 and filter fibers 420 may be inserted in a dialysis cap 435. Note that the term “dialysis cap” is for convenience is not intended to limit the scope of the invention to the manufacture of a dialyzer. The outer surface of the tube 405 lies adjacent an inner annular surface 440 of the dialysis cap and a 450 bond is formed by thermal welding or sealing using adhesive, solvent, or filling type bonding agent such as urethane to form a completed structure 480. A symmetrical structure is formed at the opposite end so that both ends of the tube 405 have a dialysate cap 435.
  • Referring now to FIGS. 8A and 8B, potting caps (not shown) are placed over the ends of the structure 480 and the ends of the fiber bundle are potted as according methods that are known in the art of manufacturing filters. A preferred method of potting is described in U.S. Pat. No. 6,872,346 for a “Method and apparatus for manufacturing filters,” which is hereby incorporated by reference as if fully set forth in its entirety herein. The result of potting is the creation of a sealed end of potting material indicated at 440 which, after hardening, is cut along a planar surface indicated at 460. The cut 460 is done in such a way that the end of the filter fibers 420 are open at the surface 465 forming. A portion of the dialysate cap 435 may be trimmed off in the process of cutting 460, as illustrated, although it will be apparent to those skilled in the art that this is not essential and instead, the fibers 420 could extend beyond the end of the dialysate cap 435 before potting such that the fibers 420 can be opened by cutting without cutting the dialysis cap 435. The completed end portion is shown in FIG. 8B, and as discussed, a symmetrical end portion may be completed at the opposite end (not shown here).
  • Referring now to FIGS. 9A through 11, the two ends 600A and 600 B of a single tube structure are indicated. Respective blood caps 505 and 605 are fitted to the ends 600A and 600B of the structure 480. Each blood cap has a respective blood port 510, 610 and one of the blood caps has a secondary port 610 which will be recognized from the discussion of embodiments such as shown and discussed with respect to FIGS. 3 through 5. The blood caps 505 and 605 have respective header spaces 645 that are preferably hydraulically shaped to ensure that no, or a minimal number of, dead (stagnant flow of blood) spaces arise when in use. In the embodiment shown, a rim 515 fits into an annular recess 470 (or rim 615 into annular recess 471). Prior to fitting the blood caps 505 and 605, a bead 605, 606, 607, 608 of adhesive or sealing material may be applied or injected in the annular recesses 470 and 471 to form a bond between the structure 480 and the respective blood caps 505 and 605. The bonding may be done by thermal, friction, solvent welding, compression bonding, or other technique. Dialysate ports 30 and 531 in the dialysate caps 435 and 425, respectively, allow dialysate to flow into and out of the space occupied by bundle 420 and in contact with the external surfaces of the filter bundle 420. For a hemofilter or other kinds of filters, such as sterile filters, reverse osmosis filters, ultrafilters, etc.; only one “dialysate” port would be required. Blood ports 510 and 610 in blood caps 505 and 605, respectively, supply blood into, and be recovered from, the header spaces 545 and 645, respectively. Air can be removed from air removal/access port 610. As explained above, removal/access port 610 can also be used for injection of anticoagulants, drugs, or other medicaments.
  • As best seen in FIGS. 10A and 10B, a small gap 685, 686 is provided between the end 407 (FIGS. 6A, 7A, 8A) of the tube 405 (FIGS. 6A, 6B) and the surface of the potting 440 to allow dialysate to flow into the space occupied by the filter bundle 420. The dialysate (or filtrate, depending on the application) is distributed by an annular dialysate manifold space 626, 626. Referring momentarily to FIG. 12, it is noted that instead of providing for the gap 685, 686 in the manner described, the fiber bundle may be extended all the way to the end 407 of the tube 405 and openings 705 can be provided to perform the function of the openings 685, 686. The same features provide for extraction of filtrate or dialysate or other fluid depending on the application. FIG. 11 shows a complete filter unit. One of the benefits of the design is that it makes it possible to confine the capital expense associated with injection molding to the dialysate and blood header reducing first costs in new filter designs. In addition, the design allows the tubular portion to be lengthened and shorted without requiring major design and manufacturing changes. Note that although injection molding is not contemplated to be a requirement for the practice of the invention or all its embodiments, it is a preferred means for achieving the high precision and economies of scale for articles of manufacture such as dialyzers, filters, and hemofilters, as well as other applications of the disclosed embodiments.
  • Referring to FIG. 13, the benefit of using a tube for the filtrate/dialysate portion of the filter can be obtained by using a single-element header cap rather than separate “dialysate” and “blood” caps. In the example shown, a one-piece cap 725 has an annular dialysate manifold 740 that is sealed by O-rings 747 against the surface of a tube 760. A blood header space 732 is in communication with a blood port 730 and the dialysate manifold 740 is in communication with a dialysate port 735. Slits 750 (configured such as illustrated in FIG. 11) allow fluid communication between the dialysate manifold 740 and the external surfaces of the fiber bundle 733. A potting plug 745, in addition to performing its normal function, serves to reinforce the cylindrical structure of the tube 760 against the pressure of the O-ring 747 seals. In this embodiment, a tube is permitted to be used with a single-element cap 725 structure providing many of the benefits of the inventions discussed above.
  • A tension band 757 may be used to ensure a good seal and provide a final shape to the one-piece cap 725 if made of a somewhat compliant resin to allow it to be removed from an injection mold despite the recess defined by the dialysate manifold 740. Alternatively, the one-piece cap 725 may have a discontinuous dialysate manifold that allows it to be created without requiring the cap to yield, the cap could be machined rather than molded, or the cap could be made of two molded pieces that are assembled into a single cap. Many variations are possible.
  • It will be understood that while the invention has been described above in conjunction with a few exemplary embodiments, the description and examples are intended to illustrate and not limit the scope of the invention. That which is described herein with respect to the exemplary embodiments can be applied to the measurement of many different formation characteristics. Thus, the scope of the invention should only be limited by the following claims.

Claims (21)

1. A blood treatment apparatus, comprising:
a blood purifier including microtubular filter membranes in a bundle with one end of said bundle terminating in a first manifold at a lower end of said blood purifier and a second end of said bundle terminating in a second manifold, blood flowing in an upward direction through said filter media during use;
said purifier having first and second header chambers forming respective passages where flow divides and coalesces in said first and second manifolds, respectively;
said second header having an outlet where a coalesced flow from said second manifold flows out of said second header;
said purifier being of generally cylindrical construction with a longitudinal axis parallel to said microtubular membranes;
a holder configured to hold said purifier in a preferred orientation in which said longitudinal axis forms an angle with respect to a direction of gravitation force and with said auxiliary port at a highest point of said second header and said outlet being positioned remote from said port, said highest point being determined with respect to said preferred orientation;
said second header having an auxiliary port;
said auxiliary port having a multi-way valve connected thereto.
2. Apparatus as in claim 1, wherein said multi-way valve is connected to a syringe to allow selective flow communication between said auxiliary port and said syringe, whereby gas may be manually drawn from said second header using said syringe.
3. Apparatus as in claim 1, wherein said multi-way valve has a syringe port and a medicament port, and is connected to a syringe by said syringe port and to a container of medicament by said medicament port to allow selective flow communication between said auxiliary port and said syringe and between said syringe and said container of medicament, whereby gas may be manually drawn from said second header using said syringe and injected into said medicament container and medicament can be selectively withdrawn from said medicament container and injected into said second header.
4. A blood treatment apparatus, comprising:
a blood dialyzer or hemofilter processing element including filter media into which blood comes in contact during use;
said processing element having a header chamber where multiple flows of blood combine;
said header chamber being at a position where blood exits a treatment portion of said blood purifier, said header chamber having at least one blood outlet and at least one auxiliary port;
a holder configured to support said dialyzer or hemofilter in a position and orientation such that air can accumulate in said header chamber in a position in said header space that is adjacent and in communication with said auxiliary port;
said auxiliary port having a multi-way valve connected thereto.
5. Apparatus as in claim 4, wherein said multi-way valve is connected to a syringe to allow selective flow communication between said auxiliary port and said syringe, whereby gas may be manually drawn from said second header using said syringe.
6. Apparatus as in claim 4, wherein said auxiliary port is opposite said blood outlet.
7. Apparatus as in claim 4, further comprising a valve connected to said auxiliary port and pre-connected and sterilized together with said blood purifier.
8. Apparatus as in claim 4, further comprising a multi-way multi-way valve valve connected to said auxiliary port and pre-connected and sterilized together with said blood purifier.
9. Apparatus as in claim 4, wherein said multi-way valve has a syringe port and a medicament port, and is connected to a syringe by said syringe port and to a container of medicament by said medicament port to allow selective flow communication between said auxiliary port and said syringe and between said syringe and said container of medicament, whereby gas may be manually drawn from said second header using said syringe and injected into said medicament container and medicament can be selectively withdrawn from said medicament container and injected into said second header.
10. Apparatus as in claim 4, further comprising a multi-way multi-way valve valve connectable to said auxiliary port and a syringe connectable to said multi-way valve, said valve, syringe, and said blood purifier forming a kit.
11. Apparatus as in claim 4, further comprising a holder, said blood purifier having a longitudinal axis and said holder being configured to support said blood purifier with said longitudinal axis at an angle with respect to the vertical, as defined with respect to the force of gravity.
12. A blood treatment apparatus, comprising:
a blood purifier including filter media into which blood comes in contact during use;
said processing element having a header chamber at a position where blood exits a portion of said blood purifier, said header chamber having at least one blood outlet and one auxiliary port remote from said at least one blood outlet;
said auxiliary port being configured to permit the removal of gas accumulated in said header chamber and addition and removal of medicament.
13. Apparatus as in claim 12, further comprising a valve connected to said auxiliary port and pre-connected and sterilized together with said blood purifier.
14. Apparatus as in claim 12, further comprising a multi-way valve connected to said auxiliary port and pre-connected and sterilized together with said blood purifier.
15. Apparatus as in claim 12, further comprising a syringe connected to said auxiliary port.
16. Apparatus as in claim 12, further comprising a holder configured to orient said blood purifier such that said at least one blood outlet is lower, with respect to a direction of gravity, than said auxiliary port.
17. Apparatus as in claim 12, wherein said multi-way valve has a syringe port and a medicament port, and is connected to a syringe by said syringe port and to a container of medicament by said medicament port to allow selective flow communication between said auxiliary port and said syringe and between said syringe and said container of medicament, whereby gas may be manually drawn from said second header using said syringe and injected into said medicament container and medicament can be selectively withdrawn from said medicament container and injected into said second header.
18. A method of using a multi-way valve connected to a filter of a blood circuit, comprising the steps of:
configuring to draw gas from the venous header of a blood filter, a multi-way valve that selectively bilaterally connects any pair of at least three connections, one connection being to the venous header of a blood filter, one connection being to a container, and one connection being to a positive displacement device configured to suck and push fluid;
drawing gas from said venous header into said positive displacement device;
configuring said multi-way valve to inject gasin said container;
injecting gasinto said container.
19. A method as in claim 18, further comprising the steps of:
drawing a medicament from said container into said positive displacement device;
configuring said multi-way valve to inject fluid into said header;
injecting medicament into said header.
20. A method as in claim 18, wherein said medicament includes blood-normal saline.
21. A method of using a multi-way valve connected to a blood circuit, comprising the steps of:
configuring to draw gas from the venous header of a blood filter, a multi-way valve that selectively bilaterally connects any pair of at least three connections, one connection being to the blood line of a blood circuit of an extracorporeal blood treatment device, one connection being to a container, and one connection being to a syringe configured to suck and push fluid;
drawing gas from said blood circuit into said syringe;
configuring said multi-way valve to inject gas into said container;
injecting gas into said container;
configuring said multi-way valve corresponding to draw a medicament from said container into said positive displacement device and so drawing;
configuring said multi-way valve to inject fluid into said blood circuit;
injecting medicament into said blood circuit.
US11/163,708 2004-10-28 2005-10-27 Blood Treatment Dialyzer/Filter Design to Remove Entrained Gas and Add Medicaments Abandoned US20060091058A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US11/163,708 US20060091058A1 (en) 2004-10-28 2005-10-27 Blood Treatment Dialyzer/Filter Design to Remove Entrained Gas and Add Medicaments
US12/432,507 US7901579B2 (en) 2004-10-28 2009-04-29 Blood treatment dialyzer/filter for permitting gas removal
US13/025,306 US20110126714A1 (en) 2004-10-28 2011-02-11 Blood treatment dialyzer/filter for permitting gas removal

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62286304P 2004-10-28 2004-10-28
US11/163,708 US20060091058A1 (en) 2004-10-28 2005-10-27 Blood Treatment Dialyzer/Filter Design to Remove Entrained Gas and Add Medicaments

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/432,507 Continuation US7901579B2 (en) 2004-10-28 2009-04-29 Blood treatment dialyzer/filter for permitting gas removal

Publications (1)

Publication Number Publication Date
US20060091058A1 true US20060091058A1 (en) 2006-05-04

Family

ID=36319501

Family Applications (6)

Application Number Title Priority Date Filing Date
US11/577,126 Abandoned US20100096311A1 (en) 2004-10-28 2005-09-16 Blood treatment dialyzer/filter design to trap entrained air in a fluid circuit
US11/163,708 Abandoned US20060091058A1 (en) 2004-10-28 2005-10-27 Blood Treatment Dialyzer/Filter Design to Remove Entrained Gas and Add Medicaments
US11/163,702 Abandoned US20060091056A1 (en) 2004-10-28 2005-10-27 Blood Treatment Filter Design to Trap Entrained Gas in a Blood Circuit
US11/163,703 Abandoned US20060091057A1 (en) 2004-10-28 2005-10-27 Blood Treatment Dialyzer/Filter Design to Trap and Remove Entrained Gas
US12/432,507 Active 2026-03-01 US7901579B2 (en) 2004-10-28 2009-04-29 Blood treatment dialyzer/filter for permitting gas removal
US13/025,306 Abandoned US20110126714A1 (en) 2004-10-28 2011-02-11 Blood treatment dialyzer/filter for permitting gas removal

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US11/577,126 Abandoned US20100096311A1 (en) 2004-10-28 2005-09-16 Blood treatment dialyzer/filter design to trap entrained air in a fluid circuit

Family Applications After (4)

Application Number Title Priority Date Filing Date
US11/163,702 Abandoned US20060091056A1 (en) 2004-10-28 2005-10-27 Blood Treatment Filter Design to Trap Entrained Gas in a Blood Circuit
US11/163,703 Abandoned US20060091057A1 (en) 2004-10-28 2005-10-27 Blood Treatment Dialyzer/Filter Design to Trap and Remove Entrained Gas
US12/432,507 Active 2026-03-01 US7901579B2 (en) 2004-10-28 2009-04-29 Blood treatment dialyzer/filter for permitting gas removal
US13/025,306 Abandoned US20110126714A1 (en) 2004-10-28 2011-02-11 Blood treatment dialyzer/filter for permitting gas removal

Country Status (2)

Country Link
US (6) US20100096311A1 (en)
WO (1) WO2006049822A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070102340A1 (en) * 2005-10-27 2007-05-10 Nxstage Medical, Inc. Blood treatment filter and method of manufacturing
US20090229466A1 (en) * 2004-10-28 2009-09-17 Brugger James M Blood treatment dialyzer/filter for permitting gas removal
WO2011032154A1 (en) * 2009-09-14 2011-03-17 The Trustees Of Columbia University In The City Of New York Filter blood fluid channel methods, devices and systems
EP3437722A4 (en) * 2016-03-31 2019-04-17 Asahi Kasei Medical Co., Ltd. Hollow fiber membrane module and method for manufacturing same
EP3437723A4 (en) * 2016-03-31 2019-04-17 Asahi Kasei Medical Co., Ltd. Hollow fiber membrane module and method for manufacturing hollow fiber membrane module

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2544612C (en) * 2003-11-24 2011-12-20 Gambro Lundia Ab Degassing device and end-cap assembly for a filter including such a degassing device
US9308307B2 (en) 2007-09-13 2016-04-12 Fresenius Medical Care Holdings, Inc. Manifold diaphragms
US9199022B2 (en) 2008-09-12 2015-12-01 Fresenius Medical Care Holdings, Inc. Modular reservoir assembly for a hemodialysis and hemofiltration system
US8535522B2 (en) 2009-02-12 2013-09-17 Fresenius Medical Care Holdings, Inc. System and method for detection of disconnection in an extracorporeal blood circuit
US8240636B2 (en) 2009-01-12 2012-08-14 Fresenius Medical Care Holdings, Inc. Valve system
US8597505B2 (en) 2007-09-13 2013-12-03 Fresenius Medical Care Holdings, Inc. Portable dialysis machine
US8105487B2 (en) 2007-09-25 2012-01-31 Fresenius Medical Care Holdings, Inc. Manifolds for use in conducting dialysis
US9358331B2 (en) 2007-09-13 2016-06-07 Fresenius Medical Care Holdings, Inc. Portable dialysis machine with improved reservoir heating system
CA3057806C (en) 2007-11-29 2021-11-23 Fresenius Medical Care Holdings, Inc. System and method for conducting hemodialysis and hemofiltration
CA2739786C (en) 2008-10-07 2018-01-02 Fresenius Medical Care Holdings, Inc. Priming system and method for dialysis systems
WO2010042667A2 (en) 2008-10-07 2010-04-15 Xcorporeal, Inc. Thermal flow meter
CN102639201B (en) 2008-10-30 2015-07-08 弗雷塞尼斯医疗保健控股公司 Modular, portable dialysis system
US8753515B2 (en) 2009-12-05 2014-06-17 Home Dialysis Plus, Ltd. Dialysis system with ultrafiltration control
US8501009B2 (en) 2010-06-07 2013-08-06 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Fluid purification system
CN102172476B (en) * 2011-03-24 2012-12-19 中国人民解放军第三军医大学野战外科研究所 Dialysis membrane fixing device
ES2640953T3 (en) 2011-10-07 2017-11-07 Outset Medical, Inc. Purification of heat exchange fluid for a dialysis system
DE102012023504A1 (en) 2012-12-03 2014-06-05 Fresenius Medical Care Deutschland Gmbh Device for the rapid venting and emptying of a filter
US9201036B2 (en) 2012-12-21 2015-12-01 Fresenius Medical Care Holdings, Inc. Method and system of monitoring electrolyte levels and composition using capacitance or induction
US9157786B2 (en) 2012-12-24 2015-10-13 Fresenius Medical Care Holdings, Inc. Load suspension and weighing system for a dialysis machine reservoir
EP2953662B1 (en) 2013-02-06 2018-08-29 NxStage Medical, Inc. Fluid circuit priming methods
US9227005B2 (en) 2013-03-14 2016-01-05 Brian J LeBerthon Method and device for treating cancer
US9354640B2 (en) 2013-11-11 2016-05-31 Fresenius Medical Care Holdings, Inc. Smart actuator for valve
ES2864727T3 (en) 2014-04-29 2021-10-14 Outset Medical Inc Dialysis system and methods
CN104986820B (en) * 2015-07-21 2017-04-26 江苏沁尔康环境电器有限公司 Exhausting method of reverse osmosis water purifier and reverse osmosis water purifier realizing exhausting method
BR122021006809B1 (en) 2015-10-31 2023-04-04 Saint-Gobain Performance Plastics Corporation FILTER CAPSULE
JP6646733B2 (en) * 2016-03-31 2020-02-14 旭化成メディカル株式会社 Blood purification system and priming method thereof
JP6953162B2 (en) * 2016-03-31 2021-10-27 旭化成メディカル株式会社 Blood purifier
JP7085800B2 (en) * 2016-03-31 2022-06-17 旭化成メディカル株式会社 Blood purifier, blood purification kit, and blood purification system
JP7025408B2 (en) 2016-08-19 2022-02-24 アウトセット・メディカル・インコーポレイテッド Peritoneal dialysis system and method
CA3131931A1 (en) 2019-02-28 2020-09-03 Qidni Labs Inc. Systems and methods of gas removal from a wearable device
US20200316279A1 (en) * 2019-04-02 2020-10-08 Fresenius Medical Care Holdings, Inc. Air management device for dialysis machines
WO2021094144A1 (en) 2019-11-12 2021-05-20 Fresenius Medical Care Deutschland Gmbh Blood treatment systems
EP4058094A1 (en) 2019-11-12 2022-09-21 Fresenius Medical Care Deutschland GmbH Blood treatment systems
EP4058093A1 (en) 2019-11-12 2022-09-21 Fresenius Medical Care Deutschland GmbH Blood treatment systems
CN114728159A (en) 2019-11-12 2022-07-08 费森尤斯医疗护理德国有限责任公司 Blood treatment system
CN113796900B (en) * 2020-06-17 2023-06-16 温州市人民医院 Laparoscope sleeve with air suction function

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218313A (en) * 1977-05-23 1980-08-19 Extracorporeal Medical Specialties, Inc. Dialysis apparatus and technique
USRE33932E (en) * 1982-09-22 1992-05-19 Terumo Corporation Hollow fiber-type artificial lung
US5885454A (en) * 1993-09-02 1999-03-23 Tsuchiya Mfg. Co., Ltd. Separation module and bundle unit of hollow thread-type porous membrane elements and methods of producing same
US20020056675A1 (en) * 2000-08-31 2002-05-16 Ramesh Hegde Gas vent filter construction incorporating a hollow fiber membrane assembly
US6641731B1 (en) * 1998-12-15 2003-11-04 Fresenius Medical Care Deutschland Filter device
US7297255B2 (en) * 2002-03-28 2007-11-20 Entegris, Inc. Mass or energy transfer cartridge and module

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201673A (en) * 1977-07-04 1980-05-06 Terumo Corporation Apparatus for dialysis of solution
US4293413A (en) * 1979-12-28 1981-10-06 Baxter Travenol Laboratories, Inc. Dialyzer blood circuit and bubble traps
SE427619B (en) * 1981-10-05 1983-04-25 Gambro Lundia Ab A filtering
SE451056B (en) * 1982-09-10 1987-08-31 Gambro Lundia Ab SLANGSET PROVIDED FOR EXTRACORPORAL TREATMENT OF BLOOD AND SIMILAR EXCESSIVE LIQUID
US4617161A (en) * 1983-09-06 1986-10-14 Baxter Travenol Laboratories, Inc. Method of manufacture for a dialyzer having improved side ports
US4651144A (en) * 1985-04-26 1987-03-17 Pagano Raymond V Security housing with motion detector
DE3709432A1 (en) * 1987-03-21 1988-10-06 Fresenius Ag CAPILLARY FILTER ARRANGEMENT FOR THE STERILIZATION OF LIQUID MEDIA
SE454847B (en) * 1987-08-31 1988-06-06 Gambro Dialysatoren DEVICE FOR DIFFUSION AND / OR FILTERING AND PROCEDURE FOR MANUFACTURING THIS DEVICE
US4976685A (en) * 1988-06-15 1990-12-11 Block Jr Frank E Method of blood-gas interface control in surgical gas traps
US5486286A (en) * 1991-04-19 1996-01-23 Althin Medical, Inc. Apparatus for performing a self-test of kidney dialysis membrane
US5698090A (en) * 1991-09-10 1997-12-16 Hospal Industrie Artificial kidney for adjusting a concentration of substance in blood
US5910252A (en) * 1993-02-12 1999-06-08 Cobe Laboratories, Inc. Technique for extracorporeal treatment of blood
DE59507027D1 (en) * 1994-07-13 1999-11-18 Fresenius Medical Care De Gmbh Substitute preparation for hemofiltration or hemodiafiltration
FR2723002B1 (en) * 1994-07-26 1996-09-06 Hospal Ind DEVICE AND METHOD FOR PREPARING A FILTRATION PROCESSING LIQUID
US5643190A (en) * 1995-01-17 1997-07-01 Medisystems Technology Corporation Flow-through treatment device
US5591344A (en) * 1995-02-13 1997-01-07 Aksys, Ltd. Hot water disinfection of dialysis machines, including the extracorporeal circuit thereof
US5676644A (en) * 1995-06-07 1997-10-14 Cobe Laboratories, Inc. Extracorporeal blood processing methods and apparatus
US5641144A (en) * 1995-06-07 1997-06-24 Cobe Laboratories, Inc. Dialyzer holder
US5774027A (en) * 1995-08-25 1998-06-30 Sanyo Electric Co., Ltd. Band-pass filter with trap circuits having different Q factors
DE19534417A1 (en) * 1995-09-16 1997-03-20 Fresenius Ag Method for checking at least one filter arranged in the dialysis fluid system of a device for extracorporeal blood treatment
DE19546027C1 (en) * 1995-12-09 1997-04-03 Fresenius Ag Appts. removing toxic substances from blood by dialysis or related techniques
US6979309B2 (en) * 1997-02-14 2005-12-27 Nxstage Medical Inc. Systems and methods for performing blood processing and/or fluid exchange procedures
US6579253B1 (en) * 1997-02-14 2003-06-17 Nxstage Medical, Inc. Fluid processing systems and methods using extracorporeal fluid flow panels oriented within a cartridge
US20010016699A1 (en) 1997-02-14 2001-08-23 Jeffrey H. Burbank Hemofiltration system
DE19708391C1 (en) * 1997-03-01 1998-10-22 Fresenius Medical Care De Gmbh Method and device for ultrafiltration in hemodialysis
DE19719555A1 (en) * 1997-05-09 1998-11-12 Kevin Business Corp Method and device for separating gas from gaseous blood
US5951870A (en) * 1997-10-21 1999-09-14 Dsu Medical Corporation Automatic priming of blood sets
US6071269A (en) * 1998-05-13 2000-06-06 Medisystems Technology Corporation Blood set and chamber
US6315895B1 (en) * 1999-12-30 2001-11-13 Nephros, Inc. Dual-stage hemodiafiltration cartridge
DE60120761T3 (en) 2000-12-11 2010-02-18 Nephros, Inc. Hemodiafiltration / hemofiltration cartridges
US20030010718A1 (en) * 2001-07-12 2003-01-16 Nxstage Medical, Inc. Hemodilution cap and methods of use in blood-processing procedures
US6649063B2 (en) * 2001-07-12 2003-11-18 Nxstage Medical, Inc. Method for performing renal replacement therapy including producing sterile replacement fluid in a renal replacement therapy unit
SE523610C2 (en) * 2001-10-02 2004-05-04 Gambro Lundia Ab Method of controlling dialysis device
DE10159620C1 (en) * 2001-12-05 2003-08-14 Fresenius Medical Care De Gmbh Method and device for monitoring the supply of substitution fluid during extracorporeal blood treatment
ITMI20020359A1 (en) * 2002-02-22 2003-08-22 Gambro Lundia Ab METHOD OF CONTROL OF THE OPERATION OF A FLOW INTERDICTION BODY AND A FLOW STOP DEVICE FOR AN EXTRA-BODY CIRCUIT
US7125396B2 (en) * 2002-12-30 2006-10-24 Cardinal Health 303, Inc. Safety catheter system and method
US6872346B2 (en) * 2003-03-20 2005-03-29 Nxstage Medical, Inc. Method and apparatus for manufacturing filters
EP1729836B1 (en) * 2004-05-07 2011-11-02 Gambro Lundia AB Blood treatment equipment and software program for controlling infusion.
US7776210B2 (en) * 2004-06-09 2010-08-17 Renal Solutions, Inc. Dialysis system
US20100096311A1 (en) * 2004-10-28 2010-04-22 Nxstage Medical, Inc Blood treatment dialyzer/filter design to trap entrained air in a fluid circuit
US20070102340A1 (en) * 2005-10-27 2007-05-10 Nxstage Medical, Inc. Blood treatment filter and method of manufacturing

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218313A (en) * 1977-05-23 1980-08-19 Extracorporeal Medical Specialties, Inc. Dialysis apparatus and technique
USRE33932E (en) * 1982-09-22 1992-05-19 Terumo Corporation Hollow fiber-type artificial lung
US5885454A (en) * 1993-09-02 1999-03-23 Tsuchiya Mfg. Co., Ltd. Separation module and bundle unit of hollow thread-type porous membrane elements and methods of producing same
US6641731B1 (en) * 1998-12-15 2003-11-04 Fresenius Medical Care Deutschland Filter device
US20020056675A1 (en) * 2000-08-31 2002-05-16 Ramesh Hegde Gas vent filter construction incorporating a hollow fiber membrane assembly
US7297255B2 (en) * 2002-03-28 2007-11-20 Entegris, Inc. Mass or energy transfer cartridge and module

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090229466A1 (en) * 2004-10-28 2009-09-17 Brugger James M Blood treatment dialyzer/filter for permitting gas removal
US20100096311A1 (en) * 2004-10-28 2010-04-22 Nxstage Medical, Inc Blood treatment dialyzer/filter design to trap entrained air in a fluid circuit
US7901579B2 (en) 2004-10-28 2011-03-08 Nxstage Medical, Inc. Blood treatment dialyzer/filter for permitting gas removal
US20110126714A1 (en) * 2004-10-28 2011-06-02 Nxstage Medical, Inc. Blood treatment dialyzer/filter for permitting gas removal
US20070102340A1 (en) * 2005-10-27 2007-05-10 Nxstage Medical, Inc. Blood treatment filter and method of manufacturing
US20090236027A1 (en) * 2005-10-27 2009-09-24 Nxstage Medical, Inc. Blood Treatment Filter and Method of Manufacturing
WO2011032154A1 (en) * 2009-09-14 2011-03-17 The Trustees Of Columbia University In The City Of New York Filter blood fluid channel methods, devices and systems
US20120234746A1 (en) * 2009-09-14 2012-09-20 John Howard Filter blood fluid channel methods, devices, and systems
EP3437722A4 (en) * 2016-03-31 2019-04-17 Asahi Kasei Medical Co., Ltd. Hollow fiber membrane module and method for manufacturing same
EP3437723A4 (en) * 2016-03-31 2019-04-17 Asahi Kasei Medical Co., Ltd. Hollow fiber membrane module and method for manufacturing hollow fiber membrane module

Also Published As

Publication number Publication date
US20060091057A1 (en) 2006-05-04
US20110126714A1 (en) 2011-06-02
US20060091056A1 (en) 2006-05-04
WO2006049822A1 (en) 2006-05-11
US20100096311A1 (en) 2010-04-22
US7901579B2 (en) 2011-03-08
US20090229466A1 (en) 2009-09-17

Similar Documents

Publication Publication Date Title
US7901579B2 (en) Blood treatment dialyzer/filter for permitting gas removal
US6635179B1 (en) Sterile fluid filtration cartridge and method for using same
EP2864025B1 (en) Capillary dialyzers
EP1680156B1 (en) Fluid distribution module and extracorporeal blood circuit including such a module
EP1433490B1 (en) Dialyzer and method for manufacturing the same
EP1532994B1 (en) Degassing device and end-cap assembly for a filter
KR100649260B1 (en) Dual-stage filtration cartridge
JP6911212B2 (en) Multipurpose cap for fluid ports on medical devices
EP2796185A1 (en) Hollow fiber membrane module and casing tube used for same
WO1996040321A1 (en) Dialysis blood tubing set
US20030057147A1 (en) Filtration device and system for biological fluids
EP1398047B1 (en) End-cap for a dialyser, dialyser and method for removing gas bubbles
US20090236027A1 (en) Blood Treatment Filter and Method of Manufacturing
AU2015299007B2 (en) Filter module
EP2404664A1 (en) A support for a separation device and extracorporeal blood treatment using said support and separation device
JP2007319542A (en) Apparatus and circuit for treatment of hemocyte preparation
CN215460731U (en) Improved blood ultrafilter and hemodialysis system
JP2000042100A (en) Hollow fiber membrane type liquid treatment apparatus
CN211535888U (en) Dialysate barrel dust cover and dialysate barrel
JP2016112089A (en) Blood purification system and blood purifier
CN113490518A (en) Dialyzer and dialysis apparatus
JP2006158456A (en) Blood purifying apparatus

Legal Events

Date Code Title Description
AS Assignment

Owner name: NXSTAGE MEDICAL INC., MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BRUGGER, JAMES M.;STILLIG, MARTIN;REEL/FRAME:016944/0574;SIGNING DATES FROM 20051219 TO 20051220

AS Assignment

Owner name: GE BUSINESS FINANCIAL SERVICES INC., CONNECTICUT

Free format text: SECURITY AGREEMENT;ASSIGNORS:NXSTAGE MEDICAL, INC.;EIR MEDICAL, INC.;MEDISYSTEMS CORPORATION;AND OTHERS;REEL/FRAME:022610/0602

Effective date: 20090316

Owner name: GE BUSINESS FINANCIAL SERVICES INC.,CONNECTICUT

Free format text: SECURITY AGREEMENT;ASSIGNORS:NXSTAGE MEDICAL, INC.;EIR MEDICAL, INC.;MEDISYSTEMS CORPORATION;AND OTHERS;REEL/FRAME:022610/0602

Effective date: 20090316

AS Assignment

Owner name: NXSTAGE MEDICAL, INC., MASSACHUSETTS

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:GE BUSINESS FINANCIAL SERVICES INC.;REEL/FRAME:022804/0150

Effective date: 20090605

Owner name: EIR MEDICAL, INC., MASSACHUSETTS

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:GE BUSINESS FINANCIAL SERVICES INC.;REEL/FRAME:022804/0150

Effective date: 20090605

Owner name: MEDISYSTEMS CORPORATION, MASSACHUSETTS

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:GE BUSINESS FINANCIAL SERVICES INC.;REEL/FRAME:022804/0150

Effective date: 20090605

Owner name: MEDISYSTEMS SERVICES CORPORATION, MASSACHUSETTS

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:GE BUSINESS FINANCIAL SERVICES INC.;REEL/FRAME:022804/0150

Effective date: 20090605

Owner name: NXSTAGE MEDICAL, INC.,MASSACHUSETTS

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:GE BUSINESS FINANCIAL SERVICES INC.;REEL/FRAME:022804/0150

Effective date: 20090605

Owner name: EIR MEDICAL, INC.,MASSACHUSETTS

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:GE BUSINESS FINANCIAL SERVICES INC.;REEL/FRAME:022804/0150

Effective date: 20090605

Owner name: MEDISYSTEMS CORPORATION,MASSACHUSETTS

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:GE BUSINESS FINANCIAL SERVICES INC.;REEL/FRAME:022804/0150

Effective date: 20090605

Owner name: MEDISYSTEMS SERVICES CORPORATION,MASSACHUSETTS

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:GE BUSINESS FINANCIAL SERVICES INC.;REEL/FRAME:022804/0150

Effective date: 20090605

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION